Maraviroc Tablet, Film Coated
Product Images NDC 73141-025

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Maraviroc (NDC 73141-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A2a Integrated Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg (150mg)

Label for Maraviroc Tablets 150 mg film-coated tablets, oral use, containing 60 tablets per container. The label includes dosage storage instructions, a note to dispense with medication guide, and is distributed by A2A Integrated Pharmaceuticals, Bowling Green, KY. The label features the proprietary name, strength, and a barcode.*

FDA Label Image

300mg (300mg)

Maraviroc 300 mg film-coated tablets label for oral use, containing 60 tablets. The label includes dosage strength, NDC 73141-025-02, dispensing instructions, storage conditions, and warnings. The product is distributed by A2A Integrated Pharmaceuticals, Bowling Green, KY.*

FDA Label Image

Chem-structure.jpg (Chem Structure.jpg)

Chemical structure of maraviroc, showing the molecular arrangement with fluorinated cyclohexane, phenyl, and triazole groups consistent with the drug's chemical identity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.